DNA microsatellite instability is associated with exacerbations in COPD

D. Makris, E. Tzortzaki, N. Tzanakis, A. Damianaki, M. Zervou, N. M. Siafakas (Heraklion, Greece)

Source: Annual Congress 2005 - COPD - exacerbations II
Session: COPD - exacerbations II
Session type: Thematic Poster Session
Number: 1978
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
D. Makris, E. Tzortzaki, N. Tzanakis, A. Damianaki, M. Zervou, N. M. Siafakas (Heraklion, Greece). DNA microsatellite instability is associated with exacerbations in COPD. Eur Respir J 2005; 26: Suppl. 49, 1978

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Microsatellite DNA instability and COPD exacerbations
Source: Eur Respir J 2008; 32: 612-618
Year: 2008



Differences between COPD and bronchiectasis at the microsatellite DNA level
Source: Annual Congress 2009 - COPD: basic science and clinical studies
Year: 2009


Differences in microsatellite DNA level between asthma and chronic obstructive pulmonary disease
Source: Eur Respir J 2006; 28: 472-478
Year: 2006



Differential diagnosis of COPD and asthma at the microsatellite DNA level
Source: Eur Respir J 2004; 24: Suppl. 48, 694s
Year: 2004

A polymorphism in DNASE1L3 is associated with severe asthma exacerbations in two-high risk populations for asthma
Source: International Congress 2019 – Understanding, monitoring and targeting severe asthma
Year: 2019

DNA-estimated ageing markers are associated with COPD
Source: International Congress 2018 – Role of omics in population studies
Year: 2018

Microsatellite DNA instability and loss of heterozygosity in asthmatic children
Source: Annual Congress 2007 - Risk factors for childhood asthma: genetic and population studies
Year: 2007


Polymorphic variation in surfactant protein B is associated with COPD exacerbations
Source: Eur Respir J 2008; 32: 938-944
Year: 2008



Markers of T2-inflammation in patients with severe asthma and concomitant COPD
Source: Virtual Congress 2020 – News on clinical evaluation of bronchiectasis, cough and inflammatory disease
Year: 2020


Microsatellite DNA instability and loss of heterozygosity in bronchial asthma
Source: Eur Respir J 2003 Dec 01;22(6):951-955
Year: 2003



Static hyperinflation and respiratory disability were associated with frequent-exacerbation phenotype in patients with severe COPD
Source: International Congress 2016 – Exploring mechanisms in health and disease
Year: 2016

The median number of COPD exacerbations per year in patients with different polymorphisms of the gene ADRB2
Source: International Congress 2015 – Notable abstracts in exacerbations, mechanisms and biomarkers in COPD
Year: 2015


Uncovering regulatory function of single nucleotide polymorphisms associated with severe COPD exacerbations
Source: Virtual Congress 2020 – Inflammatory pathways in chronic airway diseases
Year: 2020


The DNA repair transcriptome in severe COPD
Source: Eur Respir J, 52 (4) 1701994; 10.1183/13993003.01994-2017
Year: 2018



The bronchitic phenotype is associated with frequent exacerbations in COPD irrespective of chronic bacterial airway infection
Source: Annual Congress 2013 –Guidelines and exacerbations
Year: 2013

Increased interferon and decreased NRF2-PPARG signaling is associated with frequent exacerbations in COPD
Source: International Congress 2015 – Promising novel findings in translational pulmonary research
Year: 2015

Genetic comparison between severe persistent asthma and COPD
Source: Eur Respir J 2003; 22: Suppl. 45, 81s
Year: 2003

Are COPD exacerbations associated with the severity of the disease?
Source: Eur Respir J 2005; 26: Suppl. 49, 300s
Year: 2005

Evaluation of markers for exacerbations of COPD
Source: Eur Respir J 2005; 26: Suppl. 49, 283s
Year: 2005

Transcriptomic footprint of COPD patients with well-defined frequent severe exacerbations.
Source: International Congress 2019 – Exacerbations of airway diseases
Year: 2019